Compare AUID & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUID | VNRX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.5M |
| IPO Year | 2014 | 2012 |
| Metric | AUID | VNRX |
|---|---|---|
| Price | $0.41 | $0.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 438.6K | ★ 9.3M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,040,660.00 | $1,727,384.00 |
| Revenue This Year | N/A | $355.66 |
| Revenue Next Year | N/A | $849.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 130.20 | 40.04 |
| 52 Week Low | $0.34 | $0.13 |
| 52 Week High | $3.74 | $3.26 |
| Indicator | AUID | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 23.80 |
| Support Level | $0.35 | $0.23 |
| Resistance Level | $0.51 | $0.27 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 37.20 | 0.00 |
AuthID Inc is a company engaged in ensuring enterprises - Know Who's Behind the Device, for every customer or employee login and transaction, through its easy-to-integrate, patented, biometric identity platform. authID powers biometric identity proofing, biometric authentication, and account recovery with a fast, accurate, user-friendly experience. With its PrivacyKey solution, authID provides accurate biometric authentication while storing no biometric data. authID's goal is to stop fraud at onboarding, blocks deepfakes, prevents account takeover, and eliminates password risks and costs, through the faster, and accurate user identity experience demanded by the digital ecosystem Its products are: IDX Mandate for Agentic AI, PrivacyKey, Identity Verification, and Biometric Authentication.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.